Stay updated on Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedIntroduced a Locations section with Minnesota as a study site and removed the older Minnesota Locations entry and the HHS Vulnerability Disclosure link; page updated to revision v3.3.3.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2; no changes to study content or page functionality were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check50 days agoChange DetectedThe site-wide government funding status banner was removed. The banner warned that information may not be up to date due to funding lapses and directed users to cc.nih.gov and opm.gov for status updates.SummaryDifference0.3%

- Check64 days agoChange DetectedNo significant content changes were detected in the Study Details page; only minor visual/layout differences are visible between screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check93 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference3%

- Check100 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial page.